Depuy hip implant lawsuit

Smith and Nephew Inc was being accused of violating Food and Drug Administration regulations when producing its hip replacement devices.

An FDA letter addressed to chairman John G.S. Buchanan dated Dec. 21 outlined violations at a manufacturing plant in Tuttlingen, Germany.

It was signed by the FDA’s Steven D. Silverman, director, Office of Compliance, Center for Devices and Radiological Well being. The letter was posted to FDA’s website on Tuesday.

It indicates that correspondence between the firm and the FDA has been on-going for some time. It outlines 5 areas of corrective action.

Find out if you are eligible for a hip implant lawsuit